150 related articles for article (PubMed ID: 37280198)
21. System analysis based on the pyroptosis-related genes identifies GSDMC as a novel therapy target for pancreatic adenocarcinoma.
Yan C; Niu Y; Li F; Zhao W; Ma L
J Transl Med; 2022 Oct; 20(1):455. PubMed ID: 36199146
[TBL] [Abstract][Full Text] [Related]
22. A novel ribosomopathy caused by dysfunction of RPL10 disrupts neurodevelopment and causes X-linked microcephaly in humans.
Brooks SS; Wall AL; Golzio C; Reid DW; Kondyles A; Willer JR; Botti C; Nicchitta CV; Katsanis N; Davis EE
Genetics; 2014 Oct; 198(2):723-33. PubMed ID: 25316788
[TBL] [Abstract][Full Text] [Related]
23. Clinicopathological features, prognostic significance, and associated tumor cell functions of family with sequence similarity 111 member B in pancreatic adenocarcinoma.
Gong Q; Dong Q; Zhong B; Zhang T; Cao D; Zhang Y; Ma D; Cai X; Li Z
J Clin Lab Anal; 2022 Dec; 36(12):e24784. PubMed ID: 36408702
[TBL] [Abstract][Full Text] [Related]
24. ARHGAP25 Inhibits Pancreatic Adenocarcinoma Growth by Suppressing Glycolysis via AKT/mTOR Pathway.
Huang WK; Chen Y; Su H; Chen TY; Gao J; Liu Y; Yeh CN; Li S
Int J Biol Sci; 2021; 17(7):1808-1820. PubMed ID: 33994864
[TBL] [Abstract][Full Text] [Related]
25. Low frequency mutations in ribosomal proteins RPL10 and RPL5 in multiple myeloma.
Hofman IJF; Patchett S; van Duin M; Geerdens E; Verbeeck J; Michaux L; Delforge M; Sonneveld P; Johnson AW; De Keersmaecker K
Haematologica; 2017 Aug; 102(8):e317-e320. PubMed ID: 28428269
[No Abstract] [Full Text] [Related]
26. Screening and validating the core biomarkers in patients with pancreatic ductal adenocarcinoma.
Li Y; Zhu YY; Dai GP; Wu DJ; Gao ZZ; Zhang L; Fan YH
Math Biosci Eng; 2019 Nov; 17(1):910-927. PubMed ID: 31731384
[TBL] [Abstract][Full Text] [Related]
27. A novel immune checkpoint score system for prognostic evaluation in pancreatic adenocarcinoma.
Chen Y; Lin X; Zou X; Qian Y; Liu Y; Wang R; Wang X; Yu X; Liu C; Cheng H
BMC Gastroenterol; 2023 Apr; 23(1):113. PubMed ID: 37024802
[TBL] [Abstract][Full Text] [Related]
28. Deubiquitinase UCHL5 stabilizes ELK3 to potentiate cancer stemness and tumor progression in pancreatic adenocarcinoma (PAAD).
Yang Y; Cao L; Guo Z; Gu H; Zhang K; Qiu Z
Exp Cell Res; 2022 Dec; 421(2):113402. PubMed ID: 36328194
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of CBX3 in Pancreatic Adenocarcinoma Promotes Cell Cycle Transition-Associated Tumor Progression.
Chen LY; Cheng CS; Qu C; Wang P; Chen H; Meng ZQ; Chen Z
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29903985
[TBL] [Abstract][Full Text] [Related]
30.
Kuang W; Wang X; Ding J; Li J; Ji M; Chen W; Wang L; Yang P
Front Immunol; 2022; 13():805311. PubMed ID: 35154122
[TBL] [Abstract][Full Text] [Related]
31. AMP‑activated protein kinase family member 5 is an independent prognostic indicator of pancreatic adenocarcinoma: A study based on The Cancer Genome Atlas.
Xu H; Mao J; Yang X; Chen F; Song Z; Fei J; Chen W; Zhong Z; Wang X
Mol Med Rep; 2020 Nov; 22(5):4329-4339. PubMed ID: 33000197
[TBL] [Abstract][Full Text] [Related]
32. LncRNA LINC00857 strengthens the malignancy behaviors of pancreatic adenocarcinoma cells by serving as a competing endogenous RNA for miR-340-5p to upregulate TGFA expression.
Li T; Zhao H; Zhou H; Geng T
PLoS One; 2021; 16(3):e0247817. PubMed ID: 33661995
[TBL] [Abstract][Full Text] [Related]
33. Exome sequencing identifies mutation in CNOT3 and ribosomal genes RPL5 and RPL10 in T-cell acute lymphoblastic leukemia.
De Keersmaecker K; Atak ZK; Li N; Vicente C; Patchett S; Girardi T; Gianfelici V; Geerdens E; Clappier E; Porcu M; Lahortiga I; Lucà R; Yan J; Hulselmans G; Vranckx H; Vandepoel R; Sweron B; Jacobs K; Mentens N; Wlodarska I; Cauwelier B; Cloos J; Soulier J; Uyttebroeck A; Bagni C; Hassan BA; Vandenberghe P; Johnson AW; Aerts S; Cools J
Nat Genet; 2013 Feb; 45(2):186-90. PubMed ID: 23263491
[TBL] [Abstract][Full Text] [Related]
34. LINC01232 exerts oncogenic activities in pancreatic adenocarcinoma via regulation of TM9SF2.
Li Q; Lei C; Lu C; Wang J; Gao M; Gao W
Cell Death Dis; 2019 Sep; 10(10):698. PubMed ID: 31541081
[TBL] [Abstract][Full Text] [Related]
35. The ribosomal protein L10/QM-like protein is a component of the NIK-mediated antiviral signaling.
Rocha CS; Santos AA; Machado JP; Fontes EP
Virology; 2008 Oct; 380(2):165-9. PubMed ID: 18789471
[TBL] [Abstract][Full Text] [Related]
36. SQLE, A Key Enzyme in Cholesterol Metabolism, Correlates With Tumor Immune Infiltration and Immunotherapy Outcome of Pancreatic Adenocarcinoma.
You W; Ke J; Chen Y; Cai Z; Huang ZP; Hu P; Wu X
Front Immunol; 2022; 13():864244. PubMed ID: 35720314
[TBL] [Abstract][Full Text] [Related]
37. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
38. BDNF Acts as a Prognostic Factor Associated with Tumor-Infiltrating Th2 Cells in Pancreatic Adenocarcinoma.
Zhu Y; Zhang C; Zhao D; Li W; Zhao Z; Yao S; Zhao D
Dis Markers; 2021; 2021():7842035. PubMed ID: 34777634
[TBL] [Abstract][Full Text] [Related]
39. A simple strategy for the purification of native recombinant full-length human RPL10 protein from inclusion bodies.
Pereira LM; Silva LR; Alves JF; Marin N; Silva FS; Morganti L; Silva ID; Affonso R
Protein Expr Purif; 2014 Sep; 101():115-20. PubMed ID: 24967737
[TBL] [Abstract][Full Text] [Related]
40. LINC00857 regulated by ZNF460 enhances the expression of CLDN12 by sponging miR-150-5p and recruiting SRSF1 for alternative splicing to promote epithelial-mesenchymal transformation of pancreatic adenocarcinoma cells.
Zhang Y; Fang Y; Ma L; Xu J; Lv C; Deng L; Zhu G
RNA Biol; 2022; 19(1):548-559. PubMed ID: 35442145
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
